{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:11:08Z","timestamp":1791994268892,"version":"4.4.0"},"reference-count":51,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190079"],"award-info":[{"award-number":["RR190079"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["9010\u201023"],"award-info":[{"award-number":["9010\u201023"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA16672"],"award-info":[{"award-number":["CA16672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K12CA088084"],"award-info":[{"award-number":["K12CA088084"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA272295"],"award-info":[{"award-number":["P01CA272295"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA195568"],"award-info":[{"award-number":["U01CA195568"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA302435"],"award-info":[{"award-number":["U54CA302435"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial\/ethnic groups, and women remain underrepresented. Given limited\/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient perspectives on barriers to enrollment and define priorities for future interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients completed surveys developed to assess patient\u2010level factors, barriers to opportunity, attitudes toward participation, and perspectives on interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 301 participants, non\u2010Hispanic White (NHW) and patients with an income &gt;$100 k\/year reported better understanding of clinical trials compared to Hispanic (H) patients and patients with an income &lt;$50 k\/year (NHW: 58% vs. H: 40%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.015; &gt;$100 k\/year: 59.8% vs. &lt;$50 k\/year: 38.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.012). Compared to NHW, H and African American (AA) patients reported more concern regarding visit frequency (NHW: 10%; H: 27%; AA: 23%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.005), travel distance (NHW: 14%; H: 34%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.010; AA: 31%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.013), taking time off work (NHW: 9%; H: 23%\n                      <jats:italic>p<\/jats:italic>\n                      = &lt;.001; AA: 18%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.006) and study complexity (NHW: 6%; H: 20%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.008; AA: 22%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.001). Compared to male patients, female patients more commonly noted that having childcare services (male: 11%, female: 23%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.004), flexible appointment times (male: 43%, female: 62%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.015), and housing closer to the clinic\/hospital (male: 44%, female: 55%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.016) as helpful interventions to improve trial participation. Regardless of group, 71% of patients noted that insurance\/financial support would be the most helpful facilitator of clinical trial enrollment, and 88% reported their physician\u2019s advice would most influence their decision to participate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Data from this study suggest which specific strategies should be prioritized in future implementation studies to improve enrollment in lymphoma clinical trials and achieve disease population representation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.70377","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:30:41Z","timestamp":1776335441000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing patient perspectives on enrollment in lymphoma clinical trials"],"prefix":"10.1002","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7237-3530","authenticated-orcid":false,"given":"Neha","family":"Akkad","sequence":"first","affiliation":[{"name":"Hematology\/Medical Oncology Fellowship Program The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Romero","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Health Disparities Research The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna H.","family":"McNeill","sequence":"additional","affiliation":[{"name":"Department of Health Disparities Research The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[{"name":"Southwest Oncology Mercy CommonSpirit  Durango Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Westin","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Vallejo","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Yzquierdo","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ayers","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3990","authenticated-orcid":false,"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chijioke","family":"Nze","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.22.2720"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.708751"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25765"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1870"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100252"},{"key":"e_1_2_9_7_1","unstructured":"GensM.Reducing disparities in medicine: advancing equity in clinical trials. September 15 2025.https:\/\/advisory.avalerehealth.com\/insights\/reducing\u2010disparities\u2010in\u2010medicine\u2010advancing\u2010equity\u2010in\u2010clinical\u2010trials"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(24)01774\u20104"},{"key":"e_1_2_9_9_1","unstructured":"FDA.Glofitamab\u2010gxbm FDA opening remarks.FDA;\u00a02025. Accessed October 19 2025.https:\/\/www.fda.gov\/media\/186557\/download"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_243729"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100829"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy221"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29576"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0020731416689549"},{"issue":"9","key":"e_1_2_9_15_1","first-page":"5977","article-title":"Age and race distribution in patients in phase III oncology clinical trials","volume":"12","author":"Gopishetty S","year":"2020","journal-title":"Am J Transl Res"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030019"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23157"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.01.003"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.epi\u201015\u20101326"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.epi\u201015\u20100055"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29345"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102013\u201007\u2010517110"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.05.085"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33861"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1556264618764730"},{"key":"e_1_2_9_26_1","unstructured":"CISCRP (Center for Information and Study on Clinical Research Participation).Perceptions and Insights Study.2021. Accessed June 23 2025.https:\/\/www.ciscrp.org\/2021\u2010perceptions\u2010and\u2010insights\u2010study"},{"key":"e_1_2_9_27_1","volume-title":"Health Information National Trends Survey 5 (HINTS 5) Cycle 4 Methodology Report","author":"National Cancer Institute","year":"2020"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525\u20101497.1999.07048.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012981"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7298"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13187\u2010019\u201001650\u2010y"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2011.300591"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.03.005"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24028"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.m3119"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/op.21.00629"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2012.000763"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2022.100357"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2021.39.15_suppl.1577"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad013"},{"key":"e_1_2_9_41_1","unstructured":"U.S. Food and Drug Administration (FDA).Project Pragmatica.FDA Oncology Center of Excellence;2025. Accessed June 22 2025.https:\/\/www.fda.gov\/about\u2010fda\/oncology\u2010center\u2010excellence\/project\u2010pragmatica"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmorw.2024.100065"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00961"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.09.003"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2015.008946"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00191"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549\u2010020\u201005873\u20102"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/op.21.00100"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13187\u2010016\u20101051\u20100"},{"key":"e_1_2_9_50_1","unstructured":"Lymphoma Research Foundation.Financial support \u2010 patient aid grants.2025. Accessed October 23 2025.https:\/\/lymphoma.org\/resources\/supportservices\/financialsupport\/"},{"key":"e_1_2_9_51_1","unstructured":"Blood Cancer United.Patient resources;2025. Accessed October 23 2025.https:\/\/bloodcancerunited.org\/resources\/patients"},{"key":"e_1_2_9_52_1","unstructured":"National Institutes of Health.Advancing NIH\u2019s mission through a unified strategy.2025. Accessed October 23 2025.https:\/\/www.nih.gov\/about\u2010nih\/nih\u2010director\/statements\/advancing\u2010nihs\u2010mission\u2010through\u2010unified\u2010strategy"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.70377","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:04:21Z","timestamp":1779527061000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,15]]}},"alternative-id":["10.1002\/cncr.70377"],"URL":"https:\/\/doi.org\/10.1002\/cncr.70377","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2025-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70377"}}